Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.10.2022 | Case report

Fremanezumab

Uveitis and upset stomach: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Eugeni P. Real-world effectiveness and tolerability of fremanezumab for the preventive treatment of migraine in patients using concomitant gepants for acute treatment in a US neurology practice. Headache 62: 927, No. 7, Aug 2022. Available from: URL: http://doi.org/10.1111/head.14369 [abstract] Eugeni P. Real-world effectiveness and tolerability of fremanezumab for the preventive treatment of migraine in patients using concomitant gepants for acute treatment in a US neurology practice. Headache 62: 927, No. 7, Aug 2022. Available from: URL: http://​doi.​org/​10.​1111/​head.​14369 [abstract]
Metadaten
Titel
Fremanezumab
Uveitis and upset stomach: 2 case reports
Publikationsdatum
01.10.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-25449-8

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Yttrium-90